In patients with mild to moderate chronic stress, treatment improved QoL, especially when using topical creams. Future research should be done in patients with severe stress for a longer follow-up period and in patients with chronic more severe stress to evaluate the effect of treatment on QoL over a longer period.
Results suggest that a 6-week course of the medication tetrabenazine is more effective than placebo when treating generalized hyperhidrosis. This treatment may be useful when treating patients with mild to moderate-severe generalized hyperhidrosis associated with severe symptoms or chronic hyperhidrosis.
The treatment of hyperhidrosis depends on the individual's characteristics. Treatment may include medications or non-pharmacological treatments. Surgical options may increase the volume of sweating via cutaneous sweating bypass.
It seems that this condition does not require a single medical treatment as it is the result of a disturbance of the sympathetic nervous system.
About 2 million Americans were evaluated for hyperhidrosis annually. Women are affected more frequently than men. The rate of hyperhidrosis increases with age. The condition does not have the same impact as it does in Europe and is associated with more social impacts.
There are many signs that signify the presence of hyperhidrosis. These signs include the inability to dry clothing off after showering, frequent body washing, and sweating with and without heat. These symptoms, along with the unpleasantness of sweating, can cause great stress.
In most cases, hyperhidrosis has become a natural part of childhood. Children must be informed about the diagnosis, and encouraged to discuss a course of treatment with a pediatric dermatologist, who will perform a comprehensive evaluation of the condition, review medication contraindications, and provide patient education before the treatment is offered.
Hyperhidrosis has a multitude of possible causes and treatments have been explored over the years. It can be classified into four primary forms: idiopathic, secondary, congenital, and neurological. In most cases, a combination of the primary forms is the cause. This article will focus on the most common secondary causes of hyperhidrosis, including medications and alcohol dependence, as well as treatments.
Overall, this study showed no significant side effects to treatment with ETS and is effective and safe for a patient population with moderate to severe hyperhidrosis.
It is important to know that patients are advised not to sweat on the face. This includes the chest, abdomen, genitals and even the eyelids. Hyperhidrosis may also occur in patients taking antidepressants or with a history of depression, and is more likely if they are of a younger ages. I have noticed that patients with hyperhidrosis of the upper trunk are more likely to have [lower back pain](https://www.withpower.com/clinical-trials/lower-back-pain) and, more importantly, neck pain, as compared to those patients with hyperhidrosis of the lower torso.
According to our study, the treatment most commonly used in combination with any other treatments is photorefractive keratectomy (PRK). Treatment was most frequently used with surgical therapies in conjunction with other forms of therapies. Patients with hyperhidrosis who are also concerned about the aesthetics of their skin may use treatments with cosmetic aims, such as PRK, to boost the appeal of the skin.
Most medicines are effective for primary hyperhidrosis treatment. We can recommend anticholinergics for treating primary hyperhidrosis, and a low dosage anti-allergy, which can be used as a substitute for anticholinergic treatment to reduce the excessive sweating in patients with severe secondary hyperhidrosis.